When shock events impact the medicines supply chain, underlying vulnerabilities can cause it to break instead of bend, resulting in drug shortages. Such shocks can include an increase in demand due to emerging public health concerns.
Investments to create a more resilient medicines supply chain and prepare for future public health emergencies are among key provisions of the mammoth $1.7 trillion, bipartisan government appropriations bill signed in
Consumers in the United States often have access to a lot of information about the products they use and consume. Many products include information about the country of origin.
